Fig. 3: Changes in efficacy endpoints with bimagrumab, semaglutide and bimagrumab plus semaglutide versus placebo (primary plus extension treatment period; week 72). The percent LSM changes in ...
Detailed price information for Biomea Fusion Inc (BMEA-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results